Saltrol®
Therapeutic Segment:
Anti-Asthmatic
Generic Name:
Salmeterol + Fluticasone propionate
Indication
- 25mcg + 125mcg
Indicated for:
Asthma (Reversible Obstructive Airways Disease):
Saltrol is indicated in the regular treatment of asthma (Reversible Obstructive Airways Disease). This may include:
• Patients on effective maintenance doses of long-acting ß agonists and inhaled corticosteroids
• Patients who are symptomatic on current inhaled corticosteroid therapy
• Patients on regular bronchodilator therapy who require inhaled corticosteroids
Chronic Obstructive Pulmonary Disease (COPD):
• Saltrol is indicated in the regular treatment of Chronic Obstructive Pulmonary Disease (COPD) including chronic bronchitis and emphysema.